A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
Clinical trial NCT03416244 · COMPLETED
Trial details
- NCT number
- NCT03416244
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2021-11-19
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.